JAIMY THOMAS: Open Payments
NPI 1215483490 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,579 in 84 payments from 20 companies in 2025. Trend: 2023 $1,173 · 2024 $1,736 · 2025 $1,579
Food & beverage: $1,579
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $299 |
| ABBVIE INC. | 12 | $219 |
| Amgen Inc. | 13 | $168 |
| PFIZER INC. | 7 | $142 |
| Novo Nordisk Inc | 5 | $106 |
| Novartis Pharmaceuticals Corporation | 4 | $101 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $98 |
| Insmed, Inc. | 3 | $71 |
| Axsome Therapeutics, Inc. | 3 | $64 |
| GlaxoSmithKline, LLC. | 2 | $53 |
Products named: AIRSUPRA, OTEZLA, FARXIGA, LEQVIO, JARDIANCE, QULIPTA, ELIQUIS, Arikayce.
Industry payments across TX — which companies pay providers there.
